Factors associated with the healthcare expenditures of patients with multiple sclerosis in urban areas of China estimated by a generalized estimating equation
- PMID: 31984811
- DOI: 10.1080/14737167.2020.1722103
Factors associated with the healthcare expenditures of patients with multiple sclerosis in urban areas of China estimated by a generalized estimating equation
Abstract
Background: Multiple sclerosis (MS) has a significant healthcare burden. This study examined the medical cost and out-of-pocket (OOP) expenses, and quantified the impact factors contributing to the costs. Methods: This is a retrospective study in 77 Chinese urban cites from 2013 to 2015. The data included the details of the utilization of medical resources, cost, and reimbursement ratio of all patients with a diagnosis of MS. A generalized estimating equation model was used to estimate the factors influencing the direct medical cost and OOP expenses for in- and outpatients. Results: A total of 267 patients with MS were identified. The mean cost per in- and outpatient was respectively 16996.2 and 2294.2 renminbi ($2768.12 and $373.65, €2087.16 and €281.73). Approximately 27% of the expenses were paid by the patients OOP. Factors contributing to high cost and high OOP expenses for inpatients were tertiary hospital admission, length of stay and residence in the east regions of China. Females and outpatients with resident insurance paid more OOP. Conclusion: This study illustrates the medical costs and burden of MS in Chinese patients and provides real-world data on MS that are essential for the improvement of health policies.
Keywords: China; Multiple sclerosis (MS); generalized estimating equation (GEE); healthcare expenditures; medical cost; out-of-pocket (OOP) expenses.
Similar articles
-
Healthcare costs for patients with rare diseases: Evidence from China.Int J Health Plann Manage. 2024 Jan;39(1):48-61. doi: 10.1002/hpm.3713. Epub 2023 Oct 10. Int J Health Plann Manage. 2024. PMID: 37815061
-
The effect of China's new cooperative medical scheme on health expenditures among the rural elderly.Int J Equity Health. 2019 Feb 6;18(1):27. doi: 10.1186/s12939-019-0933-2. Int J Equity Health. 2019. PMID: 30728018 Free PMC article.
-
Impact of Critical Illness Insurance on the Burden of High-Cost Rural Residents in Central China: An Interrupted Time Series Study.Int J Environ Res Public Health. 2019 Sep 20;16(19):3528. doi: 10.3390/ijerph16193528. Int J Environ Res Public Health. 2019. PMID: 31547215 Free PMC article.
-
Perspectives in multiple sclerosis health care: special focus on the costs of multiple sclerosis.Autoimmun Rev. 2006 Oct;5(8):511-6. doi: 10.1016/j.autrev.2006.02.001. Epub 2006 Mar 10. Autoimmun Rev. 2006. PMID: 17027884 Review.
-
Multiple sclerosis: economic burden, therapeutic advances, and future forecasts in the Middle East and North Africa region.Expert Rev Pharmacoecon Outcomes Res. 2024 Oct;24(8):873-882. doi: 10.1080/14737167.2024.2364832. Epub 2024 Jun 7. Expert Rev Pharmacoecon Outcomes Res. 2024. PMID: 38832693 Review.
Cited by
-
Economic Burden of Multiple Sclerosis in Low- and Middle-Income Countries: A Systematic Review.Pharmacoeconomics. 2021 Jul;39(7):789-807. doi: 10.1007/s40273-021-01032-7. Epub 2021 May 6. Pharmacoeconomics. 2021. PMID: 33956330 Free PMC article.
-
Prevalence and Burden of Multiple Sclerosis in China, 1990-2019: Findings From the Global Burden of Disease Study 2019.Neurology. 2024 Jun 11;102(11):e209351. doi: 10.1212/WNL.0000000000209351. Epub 2024 May 17. Neurology. 2024. PMID: 38759127 Free PMC article.
-
Disease Burden and Costs Associated with Multiple Sclerosis in China: A Cross-sectional Analysis of Nationwide Survey Data.Neurosci Bull. 2024 Apr;40(4):533-538. doi: 10.1007/s12264-023-01135-5. Epub 2023 Nov 2. Neurosci Bull. 2024. PMID: 37917312 Free PMC article. No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical